Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
Current and future directions in the treatment of metastatic malignant melanomaJ M Baron, R Heise, H F Merk, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
Chartreusin, elsamicin A and related anti-cancer antibioticsJosé Portugal
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Cytotoxic anticancer candidates from natural resourcesJinwoong Kim, Eun Jung Park
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
The molecular mechanisms for the antitumorigenic effect of curcuminTzeng-Horng Leu, Ming-Chei Maa
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analoguesStéphanie Desbène, Sylviane Giorgi-Renault
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequencesP B Arimondo, C Hélène
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agentsI Manzanares, C Cuevas, R García-Nieto, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural productsR A Manderville
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Chemical and biological profile of dual Cdk1 and Cdk2 inhibitorsStephan Ruetz, Doriano Fabbro, Juerg Zimmermann, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Antifolates -- past, present and futureAleem Gangjee, Hiteshkumar D Jain
Pageof 19